Drug–disease interactions in Swedish senior primary care patients were dominated by non-steroid anti-inflammatory drugs and hypertension – a population-based registry study

References

• World Health Organisation. European Health Report 2012. [20 mar 2020]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0004/197113/EHR2012-Eng.pdf
   Google Scholar
• Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012; 7380(9836):37–43.
   PubMed Web of Science ®Google Scholar
• Cassell A, Edwards D, Harshfield A, et al. The epidemiology of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2018;68(669):e245–e251.
   PubMed Web of Science ®Google Scholar
• Pugh MJ, Starner CI, Amuan ME, et al. Exposure to potentially harmful drug-disease interactions in older community-dwelling veterans based on the Healthcare Effectiveness Data and Information Set quality measure: who is at risk? J Am Geriatr Soc. 2011;59(9):1673–1678.
   PubMed Web of Science ®Google Scholar
• O'Mahony D, O'Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–218.
   PubMed Web of Science ®Google Scholar
• Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc. 2012;60(10):E1–e25.
   PubMed Web of Science ®Google Scholar
• Starfield B, Lemke KW, Bernhardt T, et al. Comorbidity: implications for the importance of primary care in 'case' management. Ann Fam Med. 2003;1(1):8–14.
   PubMedGoogle Scholar
• Devik SA, Olsen RM, Fiskvik IL, et al. Variations in drug-related problems detected by multidisciplinary teams in Norwegian nursing homes and home nursing care. Scand J Prim Health Care. 2018;36(3):291–299.
   PubMed Web of Science ®Google Scholar
• Gnjidic D, Johnell K. Clinical implications from drug-drug and drug-disease interactions in older people. Clin Exp Pharmacol Physiol. 2013;40(5):320–325.
   PubMed Web of Science ®Google Scholar
• Lorgunpai SJ, Grammas M, Lee DS, et al. Potential therapeutic competition in community-living older adults in the U.S.: use of medications that may adversely affect a coexisting condition. PLoS One. 2014;9(2):e89447.
   PubMed Web of Science ®Google Scholar
• Aspinall SL, Zhao X, Semla TP, et al.; Veterans Affairs Community Living Center Pharmacotherapy Research Group. Epidemiology of drug-disease interactions in older veteran nursing home residents. J Am Geriatr Soc. 2015;63(1):77–84.
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Perera S, Newman AB, et al.; Health ABC Study. Potential drug-drug and drug-disease interactions in well-functioning community-dwelling older adults. J Clin Pharm Ther. 2017;42(2):228–233.
   PubMed Web of Science ®Google Scholar
• Mand P, Roth K, Biertz F, et al. Drug-disease interaction in elderly patients in family practice. Int J Clin Pharmacol Ther. 2014; 52(5):337–345.
   PubMed Web of Science ®Google Scholar
• Lau M, Tenney J. Evaluation of drug-disease interactions and their association with unplanned hospital readmission utilizing STOPP Version 2 Criteria. Geriatrics. 2017;2(4):33.
   Web of Science ®Google Scholar
• Gellad WF, Good CB, Amuan ME, et al. Facility-level variation in potentially inappropriate prescribing for older veterans. J Am Geriatr Soc. 2012;60(7):1222–1229.
   PubMed Web of Science ®Google Scholar
• Anell A. The public-private pendulum-patient choice and equity in Sweden. N Engl J Med. 2015;372(1):1–4.
   PubMed Web of Science ®Google Scholar
• European Observatory Health Policy Series. In: Kringos DS, Boerma WGW, Hutchinson A, editors. Building primary care in a changing Europe - Case studies. European Observatory on Health Systems and Policies: Copenhagen (Denmark), 2015. Chapter 28, 3.1: page 270.
   Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
   PubMed Web of Science ®Google Scholar
• Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735.
   PubMed Web of Science ®Google Scholar
• Wallerstedt SM, Wettermark B, Hoffmann M. The first decade with the Swedish prescribed drug register - a systematic review of the output in the scientific literature. Basic Clin Pharmacol Toxicol. 2016;119(5):464–469.
   PubMed Web of Science ®Google Scholar
• Hill-Taylor B, Walsh KA, Stewart S, et al. Effectiveness of the STOPP/START (Screening Tool of Older Persons' potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther. 2016;41(2):158–169.
   PubMed Web of Science ®Google Scholar
• Guidelines for ATC classification and DDD assignment 2013 Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2012. [10 jan 2020]. Available from: www.whocc.no
   Google Scholar
• Swedish code of statuses [Internet]. Stockholm: Swedish code of statuses. Act 2002:687,2§. 2002 [cited 2020 Feb 21]. Available from: www.sweden.gov.se
   Google Scholar
• American Geriatrics Society 2015 Updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–2246.
   PubMed Web of Science ®Google Scholar
• Hjerpe P, Merlo J, Ohlsson H, et al. Validity of registration of ICD codes and prescriptions in a research database in Swedish primary care: a cross-sectional study in Skaraborg primary care database. BMC Med Inform Decis Mak. 2010;10(1):23.
   PubMedGoogle Scholar
• Zarrinkoub R, Wettermark B, Wändell P, et al. The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail. 2013;15(9):995–1002.
   PubMed Web of Science ®Google Scholar
• Schmidt-Mende K, Wettermark B, Andersen M, et al. Prevalence of renally inappropriate medicines in older people with renal impairment - A cross-sectional register-based study in a large primary care population. Basic Clin Pharmacol Toxicol. 2019;124(3):256–265.
   PubMed Web of Science ®Google Scholar
• Christensen HN, Olsson U, From J, et al. Opioid-induced constipation, use of laxatives, and health-related quality of life. Scand J Pain. 2016;11:104–110.
   PubMed Web of Science ®Google Scholar
• Dreischulte T, Donnan P, Grant A, et al. Safer prescribing–a trial of education, informatics, and financial incentives. N Engl J Med. 2016;374(11):1053–1064.
   PubMed Web of Science ®Google Scholar
• Sanchez-Fidalgo S, Guzman-Ramos MI, Galvan-Banqueri M, et al. Prevalence of drug interactions in elderly patients with multimorbidity in primary care. Int J Clin Pharm. 2017;39(2):343–353.
   PubMed Web of Science ®Google Scholar
• Ljungman C, Kahan T, Schioler L, et al. Non-steroidal anti-inflammatory drugs and Blood Pressure Control in Patients Treated for Hypertension: results from the Swedish Primary Care Cardiovascular Database. Blood Press. 2017;26(4):220–228.
   PubMed Web of Science ®Google Scholar
• Schmidt-Mende K, Hasselstrom J, Wettermark B, et al. General practitioners' and nurses' views on medication reviews and potentially inappropriate medicines in elderly patients - a qualitative study of reports by educating pharmacists. Scand J Prim Health Care. 2018;36(3):329–341.
   PubMed Web of Science ®Google Scholar
• Mantelli S, Jungo KT, Rozsnyai Z, et al. How general practitioners would deprescribe in frail oldest-old with polypharmacy - the LESS study. BMC Fam Pract. 2018;19(1):169
   PubMedGoogle Scholar
• National Institute for Health and Care Excellence. Multimorbidity: clinical assessment and management 2016. [20 March 2020]. Available from: https://www.nice.org.uk/guidance/ng56/evidence/full-guideline-pdf-2615543103
   Google Scholar